UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine to start P1 trial of Covid-19 treatment in US
by Lee Han-soo
2020-06-11 16:26
Greater Seoul remains hot spot of Covid-19 infections
by Lee Han-soo
2020-06-11 12:08
'Imfinzi changed treatment paradigm for non-resectable NSCLC'
by Lee Han-soo
2020-06-10 17:58
Myongji Hospital to develop AI-based Covid-19 detection kit in 3-way project
by Lee Han-soo
2020-06-10 16:07
New virus cases rise back amid unrelenting cluster infections in greater Seoul
by Lee Han-soo
2020-06-10 11:49
라인
Baekje to distribute Leo Pharma's dermatology products
by Lee Han-soo
2020-06-09 16:49
LegoChem licenses in Covid-19 treatment candidates
by Lee Han-soo
2020-06-09 16:48
Researchers find recurrence cause for pemphigus
by Lee Han-soo
2020-06-09 13:37
Korean, US firms in legal battle over Covid-19 vaccine know-how
by Lee Han-soo
2020-06-08 21:28
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
by Lee Han-soo
2020-06-08 16:54
라인
Environmental chemicals causing chronic kidney disease identified
by Lee Han-soo
2020-06-08 15:14
IVI ties up with SNUH for clinical trial of Covid-19 vaccine
by Lee Han-soo
2020-06-04 17:04
[ASCO 2020 ⑤] Lunit opens possibility of personalized cancer treatment with AI platform
by Lee Han-soo
2020-06-04 16:25
MedPacto to test Vactosertib for treating NSCLC
by Lee Han-soo
2020-06-04 12:43
Dupixent to provide new treatment options for asthma patients
by Lee Han-soo
2020-06-03 17:54
라인
New plasma-based method found to treat refractory blood cancer
by Lee Han-soo
2020-06-03 16:29
Treating helicobacter bacteria after gastric cancer surgery lifts survival rate
by Lee Han-soo
2020-06-03 16:05
CDK 4/6 inhibitor market to heat up on insurance benefits
by Lee Han-soo
2020-06-02 17:13
[ASCO 2020 ②] GC confirms safety, efficacy of anti-EGFR monoclonal antibody
by Lee Han-soo
2020-06-02 11:20
[ASCO 2020 ①] Samsung Bioepis’ anticancer biosimilar shows equal quality to original drug
by Lee Han-soo
2020-06-01 16:14
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top